Fertility drug REKOVELLE under Real-World watch in 1,500 asian women
NCT ID NCT06561958
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study follows 1,500 Asian women using REKOVELLE for their first ovarian stimulation treatment as part of IVF or ICSI. Researchers track how many women have a live baby within 12 months and how the drug is used in everyday practice. The goal is to understand real-world effectiveness and safety, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ferring Investigational Site
Chiba, Chiba, 2610023, Japan
-
Ferring Investigational Site
Fukuoka, Fukuoka, 8120013, Japan
-
Ferring Investigational Site
Kitakyushu, Fukuoka, 8070825, Japan
-
Ferring Investigational Site
Takasaki, Gunma, 3700841, Japan
-
Ferring Investigational Site
Hiroshima, Hiroshima, 7320822, Japan
-
Ferring Investigational Site
Bunkyō City, Japan, 1130033, Japan
-
Ferring Investigational Site
Tokyo, Tokyo, 1600023, Japan
-
Ferring Investigational Site
Hiroshima, 7300035, Japan
-
Ferring Investigational Site
Hokkaido, 0600003, Japan
-
Ferring Investigational Site
Hyōgo, 6500021, Japan
-
Ferring Investigational Site
Osaka, 5300011, Japan
-
Ferring Investigational Site
Osaka, 5500015, Japan
-
Ferring Investigational Site
Saitama, 3540035, Japan
-
Ferring Investigational Site
Busan, Busan, 49241, South Korea
-
Ferring Investigational Site
Daegu, Daegu, 41910, South Korea
-
Ferring Investigational Site
Seongnam-si, Seongnam, 13496, South Korea
-
Ferring Investigational Site
Busan, 47245, South Korea
-
Ferring Investigational Site
Tainan, Tainan, 70403, Taiwan
-
Ferring Investigational Site
Tainan, Tainan, 71004, Taiwan
-
Ferring Investigational Site
Taoyuan, Taoyuan, 333, Taiwan
-
Ferring Investigational Site
Taichung, 406, Taiwan
-
Ferring Investigational Site
Taipei, 100225, Taiwan
-
Ferring Investigational Site
Taipei, 110, Taiwan
-
Ferring Investigational Site
Bangkok, 10700, Thailand
-
Ferring Investigational Site
Hanoi, Hanoi, 100000, Vietnam
-
Ferring Investigational Site
Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam
-
Ferring Investigational Site
Ho Chi Minh City, Ho Chi Minh City, Vietnam
-
Ferring Investigational Site
Huế, Huế, 49000, Vietnam
-
Maria Fertility Hospital
Seoul, 02586, South Korea
-
Naresuan University Hospital
Phitsanulok, Muang, 65000, Thailand
-
Ramathibodi Hospital
Bangkok, Ratchathewi, 10400, Thailand
Conditions
Explore the condition pages connected to this study.